Globe Newswire WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...\n more…
TipRanks Financial Blog Wells Fargo analyst Vik Chopra maintained a Buy rating on Enovis (ENOV - Research Report) on September 6. The company's shares closed last Friday a...\n more…
Ticker Report Enovis Co. (NYSE:ENOV - Get Free Report) has received an average recommendation of "Moderate Buy" from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. One...\n more…
Ticker Report Mesirow Institutional Investment Management Inc. increased its holdings in shares of Enovis Co. (NYSE:ENOV - Free Report) by 55.6% during the second quarter, according to the company in its most...\n more…
Zolmax Mesirow Institutional Investment Management Inc. grew its stake in shares of Enovis Co. (NYSE:ENOV - Free Report) by 55.6% during the second quarter, according to its most recent filing with the...\n more…